US › Healthcare

InfuSystems Holdings Inc (INFU)

US · Healthcare · Medical Devices

$12.32+33.62%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

$33.7M

Revenue YoY

-3.0%

Net profit

$1.0M

Profit YoY

+480.9%

EPS

$0.05

EPS estimate

$0.03

Net margin

3.0%

EPS came in at 0.05 against a street estimate of 0.03 — a beat of 66.7%.

Key statistics

Market cap

$184.5M

P/E

24.7

Forward P/E

22.7

P/B

3.14

Book value

$2.91

EPS (TTM)

$0.37

52-week high

$11.04

52-week low

$5.79

50-day MA

$9.31

200-day MA

$9.25

Beta

1.40

Analyst view

Analysts rate InfuSystems Holdings Inc a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $14.88.

Shareholding

Insiders

7.15%

Institutions

79.71%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for InfuSystems Holdings Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.